This compound is primarily utilized in the pharmaceutical industry as a chiral intermediate in the synthesis of various active pharmaceutical ingredients (APIs). Its structure, featuring a benzonitrile group and an aminoethyl moiety, makes it valuable for constructing complex molecules, particularly those requiring specific stereochemistry. It is often employed in the development of drugs targeting neurological disorders, cardiovascular diseases, and other therapeutic areas where enantiomeric purity is critical. Additionally, it serves as a building block in organic synthesis for creating ligands, catalysts, and other fine chemicals. Its hydrochloride form enhances stability and solubility, facilitating its use in research and industrial processes.